These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 25853695

  • 1. Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis.
    Klaver R, Popescu V, Voorn P, Galis-de Graaf Y, van der Valk P, de Vries HE, Schenk GJ, Geurts JJ.
    J Neuropathol Exp Neurol; 2015 May; 74(5):453-8. PubMed ID: 25853695
    [Abstract] [Full Text] [Related]

  • 2. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
    Vercellino M, Masera S, Lorenzatti M, Condello C, Merola A, Mattioda A, Tribolo A, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P.
    J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
    Schmierer K, Parkes HG, So PW, An SF, Brandner S, Ordidge RJ, Yousry TA, Miller DH.
    Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
    [Abstract] [Full Text] [Related]

  • 5. Oligodendrocyte gap junction loss and disconnection from reactive astrocytes in multiple sclerosis gray matter.
    Markoullis K, Sargiannidou I, Schiza N, Roncaroli F, Reynolds R, Kleopa KA.
    J Neuropathol Exp Neurol; 2014 Sep; 73(9):865-79. PubMed ID: 25101702
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Metabolic gene expression changes in astrocytes in Multiple Sclerosis cerebral cortex are indicative of immune-mediated signaling.
    Zeis T, Allaman I, Gentner M, Schroder K, Tschopp J, Magistretti PJ, Schaeren-Wiemers N.
    Brain Behav Immun; 2015 Aug; 48():313-25. PubMed ID: 25937052
    [Abstract] [Full Text] [Related]

  • 8. Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis.
    Gray E, Rice C, Nightingale H, Ginty M, Hares K, Kemp K, Cohen N, Love S, Scolding N, Wilkins A.
    Mult Scler; 2013 Feb; 19(2):153-61. PubMed ID: 22723571
    [Abstract] [Full Text] [Related]

  • 9. Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.
    Trapp BD, Vignos M, Dudman J, Chang A, Fisher E, Staugaitis SM, Battapady H, Mork S, Ontaneda D, Jones SE, Fox RJ, Chen J, Nakamura K, Rudick RA.
    Lancet Neurol; 2018 Oct; 17(10):870-884. PubMed ID: 30143361
    [Abstract] [Full Text] [Related]

  • 10. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.
    Peterson JW, Bö L, Mörk S, Chang A, Trapp BD.
    Ann Neurol; 2001 Sep; 50(3):389-400. PubMed ID: 11558796
    [Abstract] [Full Text] [Related]

  • 11. Neuronal loss, demyelination and volume change in the multiple sclerosis neocortex.
    Carassiti D, Altmann DR, Petrova N, Pakkenberg B, Scaravilli F, Schmierer K.
    Neuropathol Appl Neurobiol; 2018 Jun; 44(4):377-390. PubMed ID: 28419506
    [Abstract] [Full Text] [Related]

  • 12. Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex.
    Preziosa P, Kiljan S, Steenwijk MD, Meani A, van de Berg WDJ, Schenk GJ, Rocca MA, Filippi M, Geurts JJG, Jonkman LE.
    Brain; 2019 Jul 01; 142(7):1921-1937. PubMed ID: 31168614
    [Abstract] [Full Text] [Related]

  • 13. [Gray matter lesions and cognitive impairment in multiple sclerosis].
    Kawachi I, Saji E, Nishizawa M.
    Rinsho Shinkeigaku; 2014 Jul 01; 54(12):1060-2. PubMed ID: 25672709
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Grey matter pathology in multiple sclerosis.
    Bö L, Geurts JJ, Mörk SJ, van der Valk P.
    Acta Neurol Scand Suppl; 2006 Jul 01; 183():48-50. PubMed ID: 16637929
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pathological ultrastructural alterations of myelinated axons in normal appearing white matter in progressive multiple sclerosis.
    Oost W, Huitema AJ, Kats K, Giepmans BNG, Kooistra SM, Eggen BJL, Baron W.
    Acta Neuropathol Commun; 2023 Jun 20; 11(1):100. PubMed ID: 37340488
    [Abstract] [Full Text] [Related]

  • 19. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.
    Kooi EJ, Geurts JJ, van Horssen J, Bø L, van der Valk P.
    J Neuropathol Exp Neurol; 2009 Sep 20; 68(9):1021-8. PubMed ID: 19680141
    [Abstract] [Full Text] [Related]

  • 20. The central role of mitochondria in axonal degeneration in multiple sclerosis.
    Campbell GR, Worrall JT, Mahad DJ.
    Mult Scler; 2014 Dec 20; 20(14):1806-13. PubMed ID: 25122475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.